Holen Sie sich die Stockscreener-App
7.41
0.94%
-0.07
Handel nachbörslich:
7.41
Schlusskurs vom Vortag:
$7.48
Offen:
$7.43
24-Stunden-Volumen:
640.23K
Relative Volume:
0.42
Marktkapitalisierung:
$759.02M
Einnahmen:
$187.64M
Nettoeinkommen (Verlust:
$-95.00M
KGV:
-7.80
EPS:
-0.95
Netto-Cashflow:
$-69.02M
1W Leistung:
-2.37%
1M Leistung:
+10.02%
6M Leistung:
-13.84%
1J Leistung:
-46.65%
1-Tages-Spanne:
$7.215
$7.455
1-Wochen-Bereich:
$7.215
$7.705
52-Wochen-Spanne:
$5.635
$16.76
Day One Biopharmaceuticals Inc Stock (DAWN) Company Profile
Firmenname
Day One Biopharmaceuticals Inc
Sektor
Branche
Telefon
650 484-0899
Adresse
2000 SIERRA POINT PARKWAY, SUITE 501, BRISBANE
Vergleichen Sie DAWN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DAWN
Day One Biopharmaceuticals Inc
|
7.41 | 758.00M | 187.64M | -95.00M | -69.02M | -0.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Day One Biopharmaceuticals Inc Stock (DAWN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-19 | Eingeleitet | Piper Sandler | Overweight |
| 2024-10-09 | Bestätigt | Needham | Buy |
| 2024-08-01 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-04-24 | Bestätigt | Needham | Buy |
| 2023-04-25 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-02-08 | Eingeleitet | CapitalOne | Overweight |
| 2023-02-03 | Eingeleitet | Oppenheimer | Perform |
| 2022-12-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-12-14 | Eingeleitet | Needham | Buy |
| 2022-12-05 | Eingeleitet | Goldman | Buy |
| 2022-12-01 | Eingeleitet | BofA Securities | Buy |
Alle ansehen
Day One Biopharmaceuticals Inc Aktie (DAWN) Neueste Nachrichten
Is Day One Biopharmaceuticals Inc. undervalued by DCF analysisAnalyst Upgrade & Daily Oversold Bounce Ideas - khodrobank.com
What earnings revisions data tells us about Day One Biopharmaceuticals Inc.Options Play & Expert-Curated Trade Recommendations - Newser
Can you recover from losses in Day One Biopharmaceuticals Inc.Market Rally & Reliable Breakout Forecasts - Newser
Does Day One Biopharmaceuticals Inc. qualify in momentum factor screeningCEO Change & Free Community Consensus Stock Picks - Newser
What is Day One Biopharmaceuticals Inc. s P E ratio telling usJuly 2025 Snapshot & Real-Time Chart Breakout Alerts - khodrobank.com
Real time breakdown of Day One Biopharmaceuticals Inc. stock performanceTrade Ideas & Technical Pattern Based Signals - Newser
What MACD and RSI say about Day One Biopharmaceuticals Inc.Market Rally & Low Drawdown Investment Ideas - Newser
What are Day One Biopharmaceuticals Inc.’s technical support levelsTrade Volume Summary & Smart Swing Trading Alerts - khodrobank.com
Reversal indicators forming on Day One Biopharmaceuticals Inc. stock2025 Fundamental Recap & Fast Gain Swing Trade Alerts - Newser
Can swing trading help recover from Day One Biopharmaceuticals Inc. losses - Newser
What’s the fair value of Day One Biopharmaceuticals Inc. stockJuly 2025 Catalysts & Accurate Intraday Trade Tips - khodrobank.com
Sentiment analysis tools applied to Day One Biopharmaceuticals Inc.Weekly Trade Analysis & AI Enhanced Market Trend Forecasts - Newser
JonesTrading Maintains Buy Rating on Day One Biopharmaceuticals (DAWN) Following Ojemda’s FDA Approval - MSN
How to build a dashboard for Day One Biopharmaceuticals Inc. stockNew Guidance & Verified Swing Trading Watchlist - Newser
Is Day One Biopharmaceuticals Inc. stock a good dividend stockQuarterly Earnings Report & Smart Allocation Stock Reports - khodrobank.com
Is Day One Biopharmaceuticals Inc. stock a good pick for beginnersJuly 2025 Macro Moves & Daily Stock Momentum Reports - khodrobank.com
Is this a good reentry point in Day One Biopharmaceuticals Inc.Rate Cut & Daily Profit Maximizing Trade Tips - Newser
Day One Biopharmaceuticals Inc. stock daily chart insightsEarnings Risk Summary & Community Consensus Picks - Newser
Is Day One Biopharmaceuticals Inc.’s growth already priced in2025 Investor Takeaways & Low Volatility Stock Suggestions - khodrobank.com
Should you wait for a breakout in Day One Biopharmaceuticals Inc.Short Setup & Daily Volume Surge Trade Alerts - Newser
Best data tools to analyze Day One Biopharmaceuticals Inc. stockTrade Performance Summary & Verified Momentum Stock Alerts - Newser
Identifying reversal signals in Day One Biopharmaceuticals Inc.Weekly Trade Review & Verified Chart Pattern Trade Signals - Newser
Can Day One Biopharmaceuticals Inc. Regain Momentum After Breakdown getLinesFromResByArray error: size == 0 - newsyoung.net
Analyzing drawdowns of Day One Biopharmaceuticals Inc. with statistical toolsMarket Trend Summary & Reliable Momentum Entry Alerts - Newser
Analyzing Day One Biopharmaceuticals Inc. with risk reward ratio chartsNew Guidance & High Accuracy Trade Signal Alerts - Newser
Applying sector rotation models to LKFNJuly 2025 News Drivers & AI Based Buy/Sell Signal Reports - Newser
Day One Biopharmaceuticals Inc. Enters Reversal Setup in Weekly Charts2025 Market Outlook & High Conviction Buy Zone Picks - beatles.ru
How to use Fibonacci retracement on Day One Biopharmaceuticals Inc.July 2025 Summary & Safe Capital Preservation Plans - Newser
Regression analysis insights on Day One Biopharmaceuticals Inc. performanceBond Market & Smart Investment Allocation Insights - Newser
Analyzing net buyer seller activity in Day One Biopharmaceuticals Inc.Market Weekly Review & Verified Chart Pattern Trade Signals - Newser
Using data tools to time your Day One Biopharmaceuticals Inc. exitJuly 2025 Levels & Weekly High Momentum Picks - Newser
What technical models suggest about Day One Biopharmaceuticals Inc.’s comeback - Newser
Will Day One Biopharmaceuticals Inc. bounce back from current supportEntry Point & Daily Technical Forecast Reports - Newser
Trend analysis for Day One Biopharmaceuticals Inc. this weekSell Signal & Real-Time Volume Trigger Notifications - Newser
Finanzdaten der Day One Biopharmaceuticals Inc-Aktie (DAWN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Day One Biopharmaceuticals Inc-Aktie (DAWN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Dubow Adam | Gen Counsel & Secretary |
Aug 18 '25 |
Sale |
6.77 |
4,365 |
29,538 |
54,858 |
| Bender Jeremy | CHIEF EXECUTIVE OFFICER |
Aug 18 '25 |
Sale |
6.77 |
16,058 |
108,666 |
161,365 |
| Merendino Lauren | Chief Commercial Officer |
Aug 18 '25 |
Sale |
6.77 |
3,766 |
25,485 |
41,931 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):